NewcelX NCEL
NASDAQ NCEL
$3.26 -0.11 (-3.18%)
As of: Aug 21, 2026 · 1:20 PM EDT

NewcelX (NCEL) Other Accumulated Expenses (2019 - 2025)

NewcelX (NCEL) posted quarterly Other Accumulated Expenses of $434069.0 for Q2 2025, down 69.44% year-over-year from $1.4 million in Q2 2024, and up 39.45% quarter-over-quarter from $311278.0 in Q4 2024.

NewcelX (NCEL) Other Accumulated Expenses (2019 - 2025) Analysis & Trends

NewcelX (NCEL) has reported Other Accumulated Expenses for 7 consecutive years, with $434069.0 the latest figure, recorded in Q2 2025.

  • In Q2 2025, Other Accumulated Expenses fell 69.44% year-over-year to $434069.0; the TTM figure through Jun 2025 stood at $434069.0 (down 69.44% YoY), while the FY2024 annual figure was $311278.0, down 81.16% from the prior year.
  • Other Accumulated Expenses climbed to $434069.0 in Q2 2025 per NCEL's latest filing, from $311278.0 in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $1.7 million in Q4 2023 and bottomed at $4107.0 in Q4 2022.
  • Historically, Other Accumulated Expenses has averaged $683040.4 across 5 years, with a median of $665648.0 in 2021.
  • Annual changes were most pronounced in 2021 — Other Accumulated Expenses plunged 83.16% — and 2023, when it jumped 40130.58%.
  • NewcelX's Other Accumulated Expenses stood at $6877.0 in 2021, then tumbled by 40.28% to $4107.0 in 2022, then surged by 40130.58% to $1.7 million in 2023, then tumbled by 81.16% to $311278.0 in 2024, then jumped by 39.45% to $434069.0 in 2025.
  • Business Quant data shows NCEL's Other Accumulated Expenses at $434069.0 in Q2 2025, $311278.0 in Q4 2024, and $1.4 million in Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 NewcelX 12.54 Mn 10.34 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2025 434,069.00
Dec 31, 2024 311,278.00
Jun 30, 2024 1.42 Mn
Dec 31, 2023 1.65 Mn
Jun 30, 2023 986,437.00
Dec 31, 2022 4,107.00
Jun 30, 2022 666,449.00
Dec 31, 2021 6,877.00
Jun 30, 2021 665,648.00
Dec 31, 2020 40,842.00
Dec 31, 2019 12,391.00